Objective To explore the relationship between HBV-DNA and HBV immune markers in serum.
目的探讨乙型肝炎（下称乙肝）病毒DNA（HBV-DNA）与血清免疫标志物的关系。
Results It is not significantly different from the two groups of the rate of HBV-DNA negativity.
结果治疗组与对照组相比，HBV-DNA阴转率的差异无显著性意义；
Objective It is to discuss the relation between the serum HBV-DNA content and the serological marker of HBV (HBV-M).
目的探讨乙型肝炎患者血清中HBV -DNA含量与HBV血清学标志物（HBV -M）的关系。
Objective To investigate the clinical value of endpoint detection of HBV-DNA by means of fluorescent quantitive PCR.
目的运用终点法荧光定量pcr检测HBV - DNA，探讨其临床应用价值。
Objective To investigate the relationship between HBV-DNA and HBV Immunological Markers in patients who infected HBV.
目的：探讨乙型肝炎病毒（HBV）感染者HBV-DNA与病毒免疫标志物的关系。
Objective To study the effect of HBV-DNA positive serum on phenotypic transformation of renal tubular epithelial cells.
目的研究HBV - DNA阳性血清对肾小管上皮细胞表型转化的作用。
Objective The serum HBV-DNA has been extensively detected by fluorescence-quantitative real time PCR (FQ-PCR) in our country.
目的目前国内较多的医院采用荧光定量的方法对血清中的HBV - DNA进行定量检测。
Objective: To study the relationship between the common mode of HBV immunological marker in serum and the quantity of HBV-DNA.
目的：探讨乙肝病毒免疫标志物常见模式与HBV - DNA量的关系。
Objective To explore the correlation between the immune markers of HBV and HBV-DNA for the diagnosis and treatment of hepatitis b.
目的探讨乙肝病毒免疫标志物与HBV - DNA之间的相互关系，为临床诊断和治疗提供有价值的判断标准。
Objective: to develop an internal quality control substance of HBV-DNA by real time quantitative PCR and to evaluate its clinical value.
目的：制备h BV - DNA荧光定量pcr检测的室内质控物，并对其应用价值进行初步评价。
ObjectiveTo study clinical meaning of new DNA chip technique in detecting the mutation of HBV-DNA , and to offer testimony for clinical diagnosis and treatment.
应用新型基因芯片研究乙肝病毒多点基因变异在慢性乙肝患者中的意义，为临床诊断和治疗提供依据。
Objective To study clinical meaning of DNA chip technique in detecting the mutation of HBV-DNA ORF, and to offer testimony for clinical diagnosis and treatment.
目的研究HBV- DNA多点基因变异在慢性乙肝中的临床意义，为临床诊断和治疗提供依据。
Objective To study clinical significance of DNA chip technique in detecting the mutation of HBV-DNA ORF, and to offer testimony for clinical diagnosis and treatment.
目的应用新型基因芯片研究乙肝病毒多点基因变异在慢性乙肝患者中的意义，为临床诊断和治疗提供依据。
Conclusion: Lamivudine treatment could decrease the HBV-DNA and transaminase level, and delay the progression of liver fibrosis and lighten inflammation and necrosis of liver.
结论：拉米夫定治疗慢性乙型肝炎，可以明显降低血清hbv - DNA及转氨酶水平，延缓肝组织纤维化的进展，减轻肝组织的炎症坏死。
Methods an Alkaline lysis method was used to isolate serum HBV-DNA for fluorescence quantitative PCR and compared with conventional phenol-chloroform extraction method and boiling lysis method.
方法使用碱裂解法、酚氯仿法和煮沸裂解法同时提取血清hbv - DNA，比较荧光定量pcr测定的重复性和测定值的差异。
To elucidate those, a total of 743 successive in-patients with biopsy-proved CHB were included to analyse correlation of HBV DNA levels with alanine transaminase (ALT) values and liver histology.
本文对经肝活检证实的743例CHB住院病人的丙氨酸转氨酶（ALT）、病毒定量、肝组织病理分级和分期及其相互关系进行对比研究。
Three patients had 1-2 episodes of transiently detectable HBV DNA.
三名病人曾有过1-2次被检测到HBV DNA，但仅为暂时性的。
The best indicators of sustained virologic response are low pre-treatment serum HBV DNA titers and elevated alanine aminotransferase (ALT) levels.
持续性病毒学应答的最佳指标是较低的治疗前血清hbv DNA滴度和较高的谷丙转氨酶(ALT)水平。
The HBV markers and HBV DNA in poultry sera, Yolk and bovine milk whey were detected by reversed passive hemagglutination assay (RPHA), enzyme immunoassay (EIA) and polymerase chain reaction (PCR).
应用反向间接血凝试验（RPHA）、酶免疫测定（EIA）和聚合酶链反应（PCR）测定了家禽血清、卵黄和牛乳清中HBV标志物及人HBV-DNA。
Conclusions the relatively high ALT level, low HBV DNA ration and early virus response are the major factors that affect the curative effect of lamivudine in treating chronic hepatitis B.
结论治疗前较高的ALT水平，较低的HBV DNA定量值及出现早期病毒学应答是影响拉米夫定治疗慢性乙型肝炎疗效的主要因素。
Piezoelectric quartz crystal HBV DNA biosensor is easy to operate, convenient and accurate, which has a good future in clinical detection.
压电石英晶体传感器操作方便、省时，且具有较好的准确度，在临床诊断中有很好的前景。
Methods HBV genotypes were detected by polymerase chain reaction (PCR) and restriction fragment length polymorphism analysis (RFLP) in 136 HBV DNA positive patients who were born in Shanghai.
方法采用聚合酶链反应-限制性片段长度多态性分析(PCR - RFLP)检测136例HBV DNA阳性的上海籍HBV感染者的基因型。
Objective To explore the sensitivity difference between fluorescent quantity PCR (FQ-PCR) and routine PCR for HBV DNA detection.
目的探讨荧光定量聚合酶链反应(FQ PCR)与常规聚合酶链反应检测乙型肝炎病毒(HBV)敏感性的差异。
Exploratory analysis revealed that high levels of pretreatment HBV DNA had a significantly higher incidence of severe hepatitis during chemotherapy.
探索性分析提示化疗前的高hbv DNA水平患者在化疗期间将明显有急性肝炎的高发生率。
CDK4 amplification could be correlated with HBV DNA integration and the progression of HCC.
CDK4的扩增可能与HBV - DNA的整合以及肝癌的进展有关。
Conclusion the combination detection of YMDD variants, HBV DNA and HBV serum markers may define HBV reinfection after liver transplantation in the patients with hepatitis b.
结论乙型肝炎肝硬化患者肝移植后预防乙型肝炎复发应采用HBV DNA、YMDD变异及血清标志物联合检测。
Objective To quantify the HBV DNA in saliva of chronic hepatitis B patients and to study its relation to the periodontal status of the patients.
目的观察肝炎患者中不同口腔卫生指标对唾液HBV DNA状况的影响，探讨牙周健康状况在乙型肝炎传播流行中的意义。
Objective to observe the therapeutic effect of autologous cytokine-induced killer cells (CIK) on HBV DNA positive patients with liver cirrhosis.
目的观察自体细胞因子诱导杀伤细胞(CIK细胞)治疗HBV DNA阳性肝硬化患者的近期疗效。
To investigate the change of HBV DNA in children with hepatitis B. HBVM and HBV DNA were detected by microparticle enzyme immunoassay (MEIA) and PCR respectively.
了解小儿乙型肝炎病毒(HBV DNA)复制水平的变化及其临床意义。采用微粒子酶免分析法(MEIA)检测HBVM，荧光定量pcr法检h BV DNA。
Objective: To investigate the feasibility of HBV DNA vaccines.
目的：探讨HBV核酸免疫的可行性。
应用推荐